Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2017-01-11 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
发行股份购买资产暨关联交易报告书（草案）摘要（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as "发行股份购买资产暨关联交易报告书（草案）摘要（修订稿）" which translates to "Report on Issuance of Shares to Purchase Assets and Related Party Transactions (Draft) Summary (Revised)". It details a transaction involving issuance of shares to purchase assets from related parties, including detailed descriptions of the transaction parties, share issuance numbers, pricing, and financial data of the target companies. It references regulatory bodies such as the China Securities Regulatory Commission (中国证监会) and Shenzhen Stock Exchange (深交所), and mentions compliance with relevant regulations like the "上市公司重大资产重组管理办法" (Measures for the Administration of Major Asset Restructuring of Listed Companies). The document is comprehensive and contains substantive financial and transaction details, indicating it is the actual transaction report rather than a brief announcement or certification. This type of document fits the category of Capital/Financing Update (CAP) as it concerns issuance of shares to purchase assets and related party transactions, which are financing activities affecting the company's capital structure. It is not an Annual Report, Audit Report, or other categories defined. The document length (15,000 characters) and detailed content confirm it is not a mere announcement or proxy material. Therefore, the appropriate classification is CAP with high confidence.
2017-01-11 Chinese
北京市金杜律师事务所关于公司发行股份购买资产暨关联交易的专项核查法律意见
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion from a law firm (北京市金杜律师事务所) regarding a transaction involving 嘉事堂药业股份有限公司 issuing shares to purchase assets and related party transactions. It references specific regulatory inquiries from the Shenzhen Stock Exchange, discusses legal compliance, asset valuation, performance commitments, and compensation arrangements related to a major asset restructuring. The document is a specialized legal verification and opinion report related to a significant corporate transaction, not a general annual or quarterly financial report, earnings release, or management discussion. It is not a simple announcement or certification but a comprehensive legal opinion on a major asset purchase and related party transaction. This fits the category of a Regulatory Filing (RNS) as it is a regulatory compliance document providing legal opinions and verification related to a major transaction, and does not fit the other more specific categories such as Annual Report, Audit Report, or M&A filings which would be more formal transaction filings or financial reports. The document length and detail also confirm it is not a brief announcement or proxy material. Therefore, the best classification is Regulatory Filings (RNS).
2017-01-11 Chinese
发行股份购买资产暨关联交易报告书（草案）（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled "发行股份购买资产暨关联交易报告书（草案）（修订稿）" which translates to "Report on Issuance of Shares to Purchase Assets and Related Party Transactions (Draft) (Revised)". It contains detailed sections on the transaction parties, asset evaluations, transaction contracts, compliance analysis, and management discussion and analysis. The content focuses on a major asset acquisition and related party transaction, including financial advisor and legal counsel statements, asset valuation reports, transaction schemes, and regulatory compliance. This type of document is typical of a capital or financing update related to a significant corporate restructuring or asset purchase. It is not a full annual or interim report, nor an earnings release or proxy statement. It is a detailed transaction report related to issuance of shares for asset purchase and related party transactions, which fits the Capital/Financing Update category (CAP). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement. Therefore, the correct classification is CAP with high confidence.
2017-01-11 Chinese
关于重大资产重组停牌的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a major asset restructuring and the related stock suspension. It mentions the issuance of shares to purchase assets, board meeting approvals, regulatory inquiries, and the need for shareholder and regulatory approvals. The document is relatively short (938 characters) and serves as an update on the status of a capital transaction rather than the full transaction report or financial statements. It does not contain detailed financial data or comprehensive report content. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2017-01-09 Chinese
关于召开2017年第一次临时股东大会的通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2017 first extraordinary general meeting of shareholders for 嘉事堂药业股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items for shareholder approval, registration details, and proxy voting instructions. The content focuses on the announcement and procedural details for the shareholder meeting rather than the results of the vote or the meeting itself. There is no indication that this document contains the voting results or a summary of the meeting outcomes. Therefore, it is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) if it contained results, but since it is a notice of the meeting and voting procedures, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length and detail also support this classification as it is not a brief announcement nor a full report but a solicitation and information statement for the shareholder meeting.
2017-01-06 Chinese
暂不复牌的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (658 characters) related to the company's stock suspension and ongoing review of a major asset restructuring. It references other detailed announcements and reports but does not contain substantive financial data or the full report itself. It is an official notice about the stock suspension and the review process, not a full financial report or detailed filing. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2016-12-30 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.